Geneva, Switzerland · Founded 2018 · Privately Held (backing)
Developer of the next-generation radiation therapy technology designed to treat cardiac arrhythmias from outside the heart. EBAMed is based in Geneva, Switzerland and was founded in 2018. Its last reported valuation was $106 million in Jun 2025. It has raised $51.1 million.
Last reported valuation
$105.6M
Oct 2026
Priced at
—
Total raised
$51.1M
Last round
—
Cap table — not yet on record
EBAMed's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of EBAMed with a free account
·The complete investor list: 13 names
·Watch EBAMed: the Monday email on marks, rounds and moves
